HomeCompareLBPH vs PLD

LBPH vs PLD: Dividend Comparison 2026

LBPH yields 3.33% · PLD yields 3.10%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PLD wins by $5.88M in total portfolio value
10 years
LBPH
LBPH
● Live price
3.33%
Share price
$59.98
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$24.8K
Annual income
$413.26
Full LBPH calculator →
PLD
PLD
● Live price
3.10%
Share price
$132.18
Annual div
$4.10
5Y div CAGR
74.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$5.91M
Annual income
$4,750,725.19
Full PLD calculator →

Portfolio growth — LBPH vs PLD

📍 PLD pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodLBPHPLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, LBPH + PLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
LBPH pays
PLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

LBPH
Annual income on $10K today (after 15% tax)
$283.43/yr
After 10yr DRIP, annual income (after tax)
$351.27/yr
PLD
Annual income on $10K today (after 15% tax)
$263.66/yr
After 10yr DRIP, annual income (after tax)
$4,038,116.41/yr
At 15% tax rate, PLD beats the other by $4,037,765.14/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of LBPH + PLD for your $10,000?

LBPH: 50%PLD: 50%
100% PLD50/50100% LBPH
Portfolio after 10yr
$2.97M
Annual income
$2,375,569.22/yr
Blended yield
80.08%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PLD right now

LBPH
Analyst Ratings
5
Buy
4
Hold
Consensus: Buy
Price Target
$61.00
+1.7% upside vs current
Range: $16.00 — $90.00
Altman Z
63.6
Piotroski
3/9
PLD
Analyst Ratings
25
Buy
16
Hold
1
Sell
Consensus: Buy
Price Target
$136.00
+2.9% upside vs current
Range: $119.00 — $155.00
Altman Z
1.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

LBPH buys
0
PLD buys
0
No recent congressional trades found for LBPH or PLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricLBPHPLD
Forward yield3.33%3.10%
Annual dividend / share$2.00$4.10
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%74.4%
Portfolio after 10y$24.8K$5.91M
Annual income after 10y$413.26$4,750,725.19
Total dividends collected$3.8K$5.78M
Payment frequencyquarterlyquarterly
SectorStockREIT
Analyst consensusBuyBuy
Analyst price target$61.00$136.00

Year-by-year: LBPH vs PLD ($10,000, DRIP)

YearLBPH PortfolioLBPH Income/yrPLD PortfolioPLD Income/yrGap
1← crossover$11,033$333.44$11,241$540.96$208.00PLD
2$12,150$343.84$13,019$991.13$869.00PLD
3$13,354$353.85$15,801$1,870.97$2.4KPLD
4$14,652$363.48$20,609$3,701.21$6.0KPLD
5$16,051$372.73$29,919$7,867.97$13.9KPLD
6$17,556$381.59$50,631$18,617.74$33.1KPLD
7$19,175$390.07$105,528$51,352.20$86.4KPLD
8$20,915$398.17$287,364$174,449.42$266.4KPLD
9$22,785$405.89$1,081,760$774,280.77$1.06MPLD
10$24,793$413.26$5,908,209$4,750,725.19$5.88MPLD

LBPH vs PLD: Complete Analysis 2026

LBPHStock

Longboard Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing transformative medicines for neurological diseases. The company's lead product candidate is LP352, which is in a Phase 1b/2a clinical trial for the treatment of seizures associated with developmental and epileptic encephalopathies. Its preclinical product candidates include LP659 and LP143, which focuses on developing therapies for multiple neurological diseases. The company was formerly known as Arena Neuroscience, Inc. and changed its name to Longboard Pharmaceuticals, Inc. in October 2020. Longboard Pharmaceuticals, Inc. was incorporated in 2020 and is based in La Jolla, California.

Full LBPH Calculator →

PLDREIT

Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. As of December 31, 2020, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 984 million square feet (91 million square meters) in 19 countries. Prologis leases modern logistics facilities to a diverse base of approximately 5,500 customers principally across two major categories: business-to-business and retail/online fulfillment.

Full PLD Calculator →
📬

Get this LBPH vs PLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

LBPH vs SCHDLBPH vs JEPILBPH vs OLBPH vs KOLBPH vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.